Trelagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor prescribed for the management of type 2 diabetes, acting by enhancing insulin secretion through the regulation of incretin levels. This category… Read more


















































Trelagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor prescribed for the management of type 2 diabetes, acting by enhancing insulin secretion through the regulation of incretin levels. This category provides essential materials for pharmaceutical research and development, including high-quality reference standards of Trelagliptin, its related impurities, specific metabolites, and stable isotope-labelled compounds. These products are critical for comprehensive impurity profiling, method validation, and rigorous quality control within laboratory environments. Analytical chemists rely on these authenticated reference standards to accurately identify and quantify degradants and by-products, ensuring compliance with strict regulatory requirements during drug formulation and stability studies. Whether used as internal standards for mass spectrometry or for system suitability testing in chromatography, these materials support the development of precise and reliable analytical methods for this therapeutic class.